Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06839664
PHASE3
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.
Official title: A Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
610
Start Date
2024-11-11
Completion Date
2026-02-27
Last Updated
2025-02-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
HS-20094 injection
Administered SC
DRUG
Placebo injection
Administered SC
Locations (1)
Peking University People's Hospital
Beijing, Beijing Municipality, China